Views

CrossRef citations to date

Altmetric

Letters to the Editor

Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma

Eva Duvalyana School of Medicine, University of California, San Francisco, CA, USA

https://orcid.org/0009-0005-5132-6750 View further author information

Nina Shahb Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USAView further author information

Mimi Loc Department of Pharmaceutical Services, University of California, San Francisco, CA, USAView further author information

Thomas Martin IIIb Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USAView further author information

Jeffrey L. Wolfb Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USACorrespondence[email protected]
View further author information

Alfred Chungb Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USAView further author information

Shagun Arorab Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USAView further author information

Chiung-Yu Huangd Department of Epidemiology & Biostatistics, University of California, San Francisco, CA, USAView further author information

Sandy W. Wongb Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USAView further author information

show all

Click to increase image sizeClick to decrease image size

Disclosure statement

E.D., S.A., and C.Y.H report that there are no competing interests to declare. M. L. is a consultant for EUSA Pharma and Oncopeptides. T.M. receives research funding from Janssen, Amgen, and Sanofi. T.M. is a consultant for GlaxoSmithKline. J.W. is a consultant for Adaptive Biotechnologies, Teneobio, Sanofi, and Amgen. A.C. receives research funding from Caelum. N.S. receives research funding from Bluebird Bio, BMS/Celgene, Janssen, Nektar, Poseida, Precision Biosciences, Sutro Biopharma, and Teneobio. N.S. is a consultant for Amgen, CareDx, CSL Behring, GSK, Indapta Therapeutics, Karyopharm, Kite, Oncopeptides, and Sanofi. S.W.W receives research funding from Bristol-Myers Squib, Fortis, Janssen, Genentech, GSK, and Caelum. S.W.W. is on the advisory board for Sanofi and Telix. S.W.W. is a consultant for Amgen.

Additional information

Funding

This study was supported by the University of California, San Francisco School of Medicine (Summer Explore Research Grant) and the UCSF Multiple Myeloma Translational Initiative.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma

Information for

Open access

Opportunities

Help and information

Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma

Disclosure statement

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature